Eurofins Biomnis is a member of the Eurofins Clinical Diagnostics France network of laboratories.
This network pools a wide variety of disciplines together to create comprehensive, innovative clinical diagnostics solutions, embracing everything from clinical research to hyperspecialised clinical pathology.
By leveraging this widely based expertise, we are able to effectively support all participants in the healthcare chain: healthcare professionals, clinical pathology laboratories, diagnostic and pharmaceutical industries; … and day after day, we play our part in writing the next chapter in the future of medicine.
Eurofins Biomnis, European leader in specialised medical pathology, emanates from a laboratory founded by Marcel Mérieux in 1897. Eurofins Biomnis is based on a concept of specialised biology that is entirely dedicated to excellence, innovation and technological investment.
With a menu of over 3,000 assays, Eurofins Biomnis laboratories has established its reputation for the development of new novel tests and the availability of routine and esoteric tests. As a partner of first-line medical laboratories, Biomnis provides its highly skilled expertise to all its stakeholders (both private and hospital-based laboratories) on a daily basis.
Day after day, the pathologists at Eurofins Biomnis can help both their fellow pathologists and prescribing physicians with the interpretation of results and contribute to improve prevention, earlier screening tests, more precise and rapid diagnoses, as well as a greater efficacy of therapeutic treatments.
Areas of expertise
Specialised medical pathology
Eurofins Biomnis focuses mainly on specialised pathology testing, which requires highly skilled expertise, and which cannot be performed in routine private or hospital-based laboratories. Eurofins Biomnis specialises in all areas of pathology and testing is performed using the most recent and cutting-edge techniques, which necessitate complex calibrations and validations, highly qualified experts and sophisticated equipment.
Clinical trials
The Clinical Trials Department at Eurofins Biomnis was created in 1998, and runs clinical studies and develops assay methods for the pharmaceutical industry.
Our values
Striving for excellence in public health
With close to 39,000 diagnostic tests performed per day, Eurofins Biomnis is committed to providing all patients from across the globe, with access to the most specialised and innovative screening, diagnosis, and monitoring or therapeutic adjustment techniques available.
Through its long-term partnerships with International logistical courriers, Eurofins Biomnis possesses the tools and know-how to ensure sample integrity on a global scale, from collection to its arrival in Eurofins Biomnis laboratories. Eurofins Biomnis is committed to guaranteeing the same high quality of care and access to innovation to patients all over the world.
Our Commitments
Service Excellence
Eurofins Biomnis is dedicated to providing quality, viable results to its reference laboratories as quickly as possible enabling optimal patient care above all else via its range of IT solutions which facilitate information exchange with its partners in a secure and confidential manner.
Thanks to its partnerships with global transport companies for the shipment of temperature controlled pharmaceutical and medical products, Eurofins Biomnis guarantees a rapid and secure transportation of the collected specimens. Quality and traceability are at the heart of Eurofins Biomnis’ logistical requirements.
Commitment to Quality
Eurofins Biomnis’ commitment to quality is clearly highlighted through obtaining yearly external recognition for its dedication to quality management via the COFRAC accreditation for both Eurofins Biomnis Paris and Eurofins Biomnis Lyon in accordance with the stringent requirements for the standards NF EN ISO/CEI 17025 since 2000 and ISO 15189 since 2010.
With the aim of continuously monitoring and improving our level of services and going beyond the regulations in place, Eurofins Biomnis laboratories has dedicated itself to quality since 1995 in order to accompany technical and regulatory changes in pathology, both internally and externally via our stakeholders.
Ethics and transparency
The pathologists at Eurofins Biomnis are committed to practicing their professions in an ethical manner, in accordance with regulation and the professional recommendations and guidelines of the field.
We also have a Code of Practice in place for our pathologists which summarises their personal and constant commitment to serve first and foremost, patient health.